VAY736
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for VAY736, covering 2017-04-20 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma [Phase 1]